COVID-19 PRECAUTIONS:    VIEW THE practices Arizona Oncology has implemented to protect our patients and their families.
Blog     Careers     News     Bill Pay     Patient Portal     Telemedicine     

Let’s Talk Prostate Cancer for No-Shave November

November 16, 2021

Let’s Talk Prostate Cancer for No-Shave November

No-Shave November is an annual movement to bring awareness to men’s health issues in a provocative way. Men participate by growing a beard and/or mustache throughout the month of November. They take a photo of their clean-shaven face on November 1st and a final picture on the 30th. Hopefully, during the thirty days in between, they can have conversations about important men’s health topics, including prostate cancer.

Prostate Cancer is the second-most common cancer affecting men

Read More

Prostate Cancer Risks, Signs, Symptoms and Screening

August 11, 2020

Prostate Cancer Risks, Signs, Symptoms and Screening

Prostate cancer is the most commonly diagnosed cancer in men after skin cancer. One in nine men will be diagnosed with prostate cancer in their lifetime. Learning the facts about the risk factors, screenings, and symptoms can help you understand your risks and create a personal medical plan.

Risk Factors of Prostate Cancer

Prostate cancer typically has nothing to do with your lifestyle or personal habits. However, there are certain indicators that could signal you are at an increased risk of getting the disease. If you have a combination of risk factors, your doctor may suggest you have certain screenings earlier or more often than what is generally recommended.

Read More

7 Things You Didn’t Know About Prostate Cancer

December 17, 2019

Learn about prostate cancer

Prostate cancer is the most common cancer among men, about 1 in 9 men will be diagnosed in their lifetime. Below are seven things that you may not know about prostate cancer that can help you detect it earlier and understand this type of cancer better if you have received a diagnosis.

  1. The majority of men survive a prostate cancer diagnosis.
  2. Prostate cancer can affect men of all ages.
  3. Symptoms may be difficult to recognize.
  4. It can be hereditary.
  5. Treatment isn’t always the first option.
  6. Prostate cancer is more common in some races.
  7. Lifestyle may affect your likelihood of getting prostate cancer.

Read More

How to Read a Prostate Cancer Pathology Report

November 20, 2019

Prostate Cancer Pathology Report

If you’re scheduled for a prostate biopsy, your doctor is likely testing a tumor for cancer. During this outpatient procedure, tissue will be removed from the tumor using a needle. It will then be analyzed by a pathologist, a doctor who reviews the results of the biopsy and provides information about the findings. The results of your biopsy are provided in a pathology report.

Your oncologist or urologist will use the pathology report as a key piece of information in determining if cancer is present and the stage, based on the cell structure in the tumor. It will also play a key role in determining whether treatment is needed at this time.

Read More

What is a Gleason Score for Prostate Cancer and What Does It Mean?

November 18, 2019

Gleason Score for Prostate Cancer

The Gleason Score is more than likely one of the first things your doctor will discuss if you have received a prostate cancer diagnosis. That’s because it’s used to explain the stage of prostate cancer you have. Let’s discuss prostate cancer, the purpose of the Gleason Score, how it is calculated, and why it is so important.  

What is Prostate Cancer?

The prostate is a gland found only in males that lies just below the bladder and in front of the rectum. Prostates in younger men are about the size of walnuts but tend to become larger as they age. It serves two main functions in the body. The first is to secrete prostate fluid (one of the components that comprises semen) and the second is to help move the seminal fluid into the urethra during ejaculation with the use of muscles.

Read More

FOLLOW US:
Arizona Oncology - The US Oncology Network